about
Sulf1 and Sulf2 Differentially Modulate Heparan Sulfate Proteoglycan Sulfation during Postnatal Cerebellum Development: Evidence for Neuroprotective and Neurite Outgrowth Promoting Functions3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3.ScFv antibody-induced translocation of cell-surface heparan sulfate proteoglycan to endocytic vesicles: evidence for heparan sulfate epitope specificity and role of both syndecan and glypican.Structure and epitope distribution of heparan sulfate is disrupted in experimental lung hypoplasia: a glycobiological epigenetic cause for malformation?The heparan sulfate motif (GlcNS6S-IdoA2S)3, common in heparin, has a strict topography and is involved in cell behavior and disease.Differential distribution of heparan sulfate glycoforms and elevated expression of heparan sulfate biosynthetic enzyme genes in the brain of mucopolysaccharidosis IIIB mice.Interactions between Skeletal Muscle Myoblasts and their Extracellular Matrix Revealed by a Serum Free Culture System.Age-related changes in rat myocardium involve altered capacities of glycosaminoglycans to potentiate growth factor functions and heparan sulfate-altered sulfationRevascularization of decellularized lung scaffolds: principles and progressHeparan Sulfate in the Developing, Healthy, and Injured Lung.Characterization of the interaction between the chlamydial adhesin OmcB and the human host cell.Proteoglycans: key regulators of pulmonary inflammation and the innate immune response to lung infectionNew targets for glycosaminoglycans and glycosaminoglycans as novel targets.'Immunosequencing' of heparan sulfate from human cell lines and rat kidney: the (GlcNS6S-IdoA2S)₃ motif, recognized by antibody NS4F5, is located towards the non-reducing end.Identification of glycosaminoglycans in human airway secretions.Plasminogen-mediated activation and release of hepatocyte growth factor from extracellular matrix.More than a biomarker: the systemic consequences of heparan sulfate fragments released during endothelial surface layer degradation (2017 Grover Conference Series).
P2860
Q28550135-D9EBDBE9-5BA5-4C89-8996-8440BF19D28BQ33230192-223E8258-DAAD-443C-86C8-1268719E199CQ33506936-E40C33EA-AE57-4260-8DF2-8B55C820E4C9Q33932177-4DED7E5B-B967-4D34-AA21-0DB235D191B3Q34412830-55A66F45-DEBB-4ADC-BAA2-0E20E0B1796AQ34757062-F74A70F9-8938-49CF-BFB4-C8D5099B9D6BQ35648510-E2FDAD86-A9D5-48E1-954D-4055DC02AE4BQ35879491-EA8BF5EF-64D4-4BAA-A527-8E3FC9331FCAQ36345871-7623BBEF-A243-43E8-8295-C9C7AFBC1B21Q37088291-5C33CCE7-B761-4293-96F3-9823232BAD76Q37335962-B0083B89-61CE-4243-A3E1-CE94D0F0C42EQ37760881-662E88F7-82E3-458E-A7AE-4BE96E074FB8Q38081956-47A93981-2B18-44AB-89A5-60AC4347C048Q38995855-1B90742B-5A73-4F7F-90DA-F30BE371BBEEQ42050150-49BCC883-665D-45F9-B564-6BC595719241Q42799009-B1EFA768-3F2B-49C6-A435-AD8ED4EDB08CQ47143359-D3239343-619B-4A1A-9A7A-AF510B533232
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Heterogeneity of heparan sulfates in human lung.
@ast
Heterogeneity of heparan sulfates in human lung.
@en
type
label
Heterogeneity of heparan sulfates in human lung.
@ast
Heterogeneity of heparan sulfates in human lung.
@en
prefLabel
Heterogeneity of heparan sulfates in human lung.
@ast
Heterogeneity of heparan sulfates in human lung.
@en
P2093
P2860
P356
P1476
Heterogeneity of heparan sulfates in human lung.
@en
P2093
Antoine A Robbesom
Elly M M Versteeg
Els M A van de Westerlo
Nicole C Smits
P N Richard Dekhuijzen
Toin H van Kuppevelt
P2860
P304
P356
10.1165/RCMB.2003-0198OC
P577
2003-08-01T00:00:00Z